Monoklonális antitest (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Monoklonális antitest" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

23nih.gov

4^th place

11^th place

18doi.org

2^nd place

8^th place

3fda.gov

447^th place

591^st place

2thelancet.com

2,393^rd place

8,307^th place

1cancer.gov

1,684^th place

2,306^th place

1cell.com

2,814^th place

2,018^th place

1science.org

1,160^th place

3,922^nd place

1worldcat.org

5^th place

22^nd place

1whatisbiotechnology.org

low place

1archive.today

14^th place

47^th place

1cam.ac.uk

670^th place

2,204^th place

1australianprescriber.com

low place

1archive.org

6^th place

14^th place

1nature.com

234^th place

267^th place

1springer.com

274^th place

438^th place

1cancer.org

3,680^th place

4,026^th place

1mayoclinic.org

1,610^th place

2,583^rd place

1medicinenet.com

3,840^th place

low place

archive.org

Pharmacology. Edinburgh: Churchill Livingstone, 241, for the examples infliximab, basiliximab, abciximab, daclizumab, palivusamab, gemtuzumab, alemtuzumab and rituximab, and mechanism and mode. o. (2003). ISBN 978-0-443-07145-4

archive.today

Dr. George Pieczenik. LMB Alumni. MRC Laboratory of Molecular Biology (LMB), 2009. szeptember 17. [2012. december 23-i dátummal az eredetiből archiválva]. (Hozzáférés: 2012. november 17.)

australianprescriber.com

Australian Prescriber (2006). „Monoclonal antibody therapy for non-malignant disease”. Australian Prescriber 29 (5), 130–33. o. DOI:10.18773/austprescr.2006.079.

cam.ac.uk

www2.mrc-lmb.cam.ac.uk

Dr. George Pieczenik. LMB Alumni. MRC Laboratory of Molecular Biology (LMB), 2009. szeptember 17. [2012. december 23-i dátummal az eredetiből archiválva]. (Hozzáférés: 2012. november 17.)

cancer.gov

home.ccr.cancer.gov

Cytochrome P450 Mediated Drug and Carcinogen Metabolism using Monoclonal Antibodies. home.ccr.cancer.gov . (Hozzáférés: 2018. április 2.)

cancer.org

Monoclonal antibodies to treat cancer | American Cancer Society. www.cancer.org . (Hozzáférés: 2018. április 19.)

cell.com

Gelboin HV, Krausz KW, Gonzalez FJ, Yang TJ (1999. november 1.). „Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery”. Trends in Pharmacological Sciences 20 (11), 432–438. o. DOI:10.1016/S0165-6147(99)01382-6. PMID 10542439.

doi.org

dx.doi.org

Gelboin HV, Krausz KW, Gonzalez FJ, Yang TJ (1999. november 1.). „Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery”. Trends in Pharmacological Sciences 20 (11), 432–438. o. DOI:10.1016/S0165-6147(99)01382-6. PMID 10542439.
Waldmann, Thomas A. (1991. június 21.). „Monoclonal Antibodies in Diagnosis and Therapy” (angol nyelven). Science 252 (5013), 1657–1662. o. DOI:10.1126/science.2047874. PMID 2047874.
(2021. december 23.) „Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19” (english nyelven). The Lancet Infectious Diseases. DOI:10.1016/S1473-3099(21)00762-3. ISSN 1473-3099. PMID 34953521. PMC 8700277.
(1994. július 1.) „Monoclonal antibodies: a witness seminar in contemporary medical history”. Medical History 38 (3), 322–27. o. DOI:10.1017/s0025727300036632. PMID 7934322. PMC 1036884.
(1973. augusztus 1.) „Human x mouse somatic cell hybrid clone secreting immunoglobulins of both parental types”. Nature 244 (5416), 444–47. o. DOI:10.1038/244444a0. PMID 4200460.
Riechmann L, Clark M, Waldmann H, Winter G (1988. március 1.). „Reshaping human antibodies for therapy”. Nature 332 (6162), 323–27. o. DOI:10.1038/332323a0. PMID 3127726.
(2018. november 1.) „A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens”. Immunology 155 (3), 283–84. o. DOI:10.1111/imm.13008. PMID 30320408. PMC 6187215.
(2018. június 1.) „Inaugural Editorial: Searching for Magic Bullets”. Antibody Therapeutics 1 (1), 1–5. o. DOI:10.1093/abt/tby001. PMID 30101214. PMC 6086361.
(2019. augusztus 1.) „Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering”. Science Advances 5 (8), eaaw1822. o. DOI:10.1126/sciadv.aaw1822. PMID 31489367. PMC 6713500.
(2002. január 1.) „Recombinant monoclonal antibody technology”. Transfusion Clinique et Biologique 9 (1), 15–22. o. DOI:10.1016/S1246-7820(01)00210-5. PMID 11889896.
(2000) „Phage display: a molecular tool for the generation of antibodies – a review”. Placenta 21 Suppl A (Suppl A), S106–12. o. DOI:10.1053/plac.1999.0511. PMID 10831134.
(1984) „Production of functional chimaeric mouse/human antibody”. Nature 312 (5995), 643–46. o. DOI:10.1038/312643a0. PMID 6095115.
(2001. április 1.) „Therapeutic antibody expression technology”. Current Opinion in Biotechnology 12 (2), 188–94. o. DOI:10.1016/S0958-1669(00)00198-1. PMID 11287236.
(1995) „Human antibodies from transgenic mice”. International Reviews of Immunology 13 (1), 65–93. o. DOI:10.3109/08830189509061738. PMID 7494109.
(2000. február 1.) „Therapeutic monoclonal antibodies”. Lancet 355 (9205), 735–40. o. DOI:10.1016/S0140-6736(00)01034-5. PMID 10703815.
Australian Prescriber (2006). „Monoclonal antibody therapy for non-malignant disease”. Australian Prescriber 29 (5), 130–33. o. DOI:10.18773/austprescr.2006.079.
(2001. november 1.) „Improving the efficacy of antibody-based cancer therapies”. Nature Reviews. Cancer 1 (2), 118–29. o. DOI:10.1038/35101072. PMID 11905803.
(2021. december 1.) „Omicron overpowers key COVID antibody treatments in early tests”. Nature. DOI:10.1038/d41586-021-03829-0. PMID 34937889.

fda.gov

(9 February 2021). "FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19". Sajtóközlemény. Ez a cikk ebből a forrásból származó szöveget tartalmaz, amely közkincs.
(21 November 2020). "Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19". Sajtóközlemény. Ez a cikk ebből a forrásból származó szöveget tartalmaz, amely közkincs.
Emergency Use Authorization letter (PDF). U.S. Food and Drug Administration (FDA) , 2021. december 16. (Hozzáférés: 2022. január 6.) Ez a cikk ebből a forrásból származó szöveget tartalmaz, amely közkincs.

mayoclinic.org

„Monoclonal antibody drugs for cancer: How they work”, Mayo Clinic (Hozzáférés: 2018. április 19.)

medicinenet.com

„Monoclonal Antibodies: List, Types, Side Effects & FDA Uses (Cancer)”, MedicineNet (Hozzáférés: 2018. április 19.)

nature.com

(2021. december 1.) „Omicron overpowers key COVID antibody treatments in early tests”. Nature. DOI:10.1038/d41586-021-03829-0. PMID 34937889.

nih.gov

pubmed.ncbi.nlm.nih.gov

Gelboin HV, Krausz KW, Gonzalez FJ, Yang TJ (1999. november 1.). „Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery”. Trends in Pharmacological Sciences 20 (11), 432–438. o. DOI:10.1016/S0165-6147(99)01382-6. PMID 10542439.
Waldmann, Thomas A. (1991. június 21.). „Monoclonal Antibodies in Diagnosis and Therapy” (angol nyelven). Science 252 (5013), 1657–1662. o. DOI:10.1126/science.2047874. PMID 2047874.
(2021. december 23.) „Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19” (english nyelven). The Lancet Infectious Diseases. DOI:10.1016/S1473-3099(21)00762-3. ISSN 1473-3099. PMID 34953521. PMC 8700277.
(1994. július 1.) „Monoclonal antibodies: a witness seminar in contemporary medical history”. Medical History 38 (3), 322–27. o. DOI:10.1017/s0025727300036632. PMID 7934322. PMC 1036884.
(1973. augusztus 1.) „Human x mouse somatic cell hybrid clone secreting immunoglobulins of both parental types”. Nature 244 (5416), 444–47. o. DOI:10.1038/244444a0. PMID 4200460.
Riechmann L, Clark M, Waldmann H, Winter G (1988. március 1.). „Reshaping human antibodies for therapy”. Nature 332 (6162), 323–27. o. DOI:10.1038/332323a0. PMID 3127726.
(2018. november 1.) „A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens”. Immunology 155 (3), 283–84. o. DOI:10.1111/imm.13008. PMID 30320408. PMC 6187215.
(2018. június 1.) „Inaugural Editorial: Searching for Magic Bullets”. Antibody Therapeutics 1 (1), 1–5. o. DOI:10.1093/abt/tby001. PMID 30101214. PMC 6086361.
(2019. augusztus 1.) „Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering”. Science Advances 5 (8), eaaw1822. o. DOI:10.1126/sciadv.aaw1822. PMID 31489367. PMC 6713500.
(2002. január 1.) „Recombinant monoclonal antibody technology”. Transfusion Clinique et Biologique 9 (1), 15–22. o. DOI:10.1016/S1246-7820(01)00210-5. PMID 11889896.
(2000) „Phage display: a molecular tool for the generation of antibodies – a review”. Placenta 21 Suppl A (Suppl A), S106–12. o. DOI:10.1053/plac.1999.0511. PMID 10831134.
(1984) „Production of functional chimaeric mouse/human antibody”. Nature 312 (5995), 643–46. o. DOI:10.1038/312643a0. PMID 6095115.
(2001. április 1.) „Therapeutic antibody expression technology”. Current Opinion in Biotechnology 12 (2), 188–94. o. DOI:10.1016/S0958-1669(00)00198-1. PMID 11287236.
(1995) „Human antibodies from transgenic mice”. International Reviews of Immunology 13 (1), 65–93. o. DOI:10.3109/08830189509061738. PMID 7494109.
(2000. február 1.) „Therapeutic monoclonal antibodies”. Lancet 355 (9205), 735–40. o. DOI:10.1016/S0140-6736(00)01034-5. PMID 10703815.
(2001. november 1.) „Improving the efficacy of antibody-based cancer therapies”. Nature Reviews. Cancer 1 (2), 118–29. o. DOI:10.1038/35101072. PMID 11905803.
(2021. december 1.) „Omicron overpowers key COVID antibody treatments in early tests”. Nature. DOI:10.1038/d41586-021-03829-0. PMID 34937889.

ncbi.nlm.nih.gov

(2021. december 23.) „Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19” (english nyelven). The Lancet Infectious Diseases. DOI:10.1016/S1473-3099(21)00762-3. ISSN 1473-3099. PMID 34953521. PMC 8700277.
(1994. július 1.) „Monoclonal antibodies: a witness seminar in contemporary medical history”. Medical History 38 (3), 322–27. o. DOI:10.1017/s0025727300036632. PMID 7934322. PMC 1036884.
(2018. november 1.) „A Nobel Prize-worthy pursuit: cancer immunology and harnessing immunity to tumour neoantigens”. Immunology 155 (3), 283–84. o. DOI:10.1111/imm.13008. PMID 30320408. PMC 6187215.
National Research Council (US) Committee on Methods of Producing Monoclonal Antibodies. Recommendation 1: Executive Summary: Monoclonal Antibody Production. Washington (DC): National Academies Press (US); 1999. ISBN 978-0-309-07511-4
(2018. június 1.) „Inaugural Editorial: Searching for Magic Bullets”. Antibody Therapeutics 1 (1), 1–5. o. DOI:10.1093/abt/tby001. PMID 30101214. PMC 6086361.
(2019. augusztus 1.) „Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering”. Science Advances 5 (8), eaaw1822. o. DOI:10.1126/sciadv.aaw1822. PMID 31489367. PMC 6713500.

science.org

Waldmann, Thomas A. (1991. június 21.). „Monoclonal Antibodies in Diagnosis and Therapy” (angol nyelven). Science 252 (5013), 1657–1662. o. DOI:10.1126/science.2047874. PMID 2047874.

springer.com

adisinsight.springer.com

Staff, Adis Insight. Bavituximab profile Last updated 27 January 2016

thelancet.com

(2021. december 23.) „Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19” (english nyelven). The Lancet Infectious Diseases. DOI:10.1016/S1473-3099(21)00762-3. ISSN 1473-3099. PMID 34953521. PMC 8700277.
(2000. február 1.) „Therapeutic monoclonal antibodies”. Lancet 355 (9205), 735–40. o. DOI:10.1016/S0140-6736(00)01034-5. PMID 10703815.

whatisbiotechnology.org

The Story of César Milstein and Monoclonal Antibodies. WhatisBiotechnology.org . (Hozzáférés: 2020. szeptember 23.)

worldcat.org

(2021. december 23.) „Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19” (english nyelven). The Lancet Infectious Diseases. DOI:10.1016/S1473-3099(21)00762-3. ISSN 1473-3099. PMID 34953521. PMC 8700277.